[新加坡2019冠状病毒病疫苗接种策略研究]
[Research on COVID-19 vaccination strategies in Singapore].
作者信息
Yi H Y, Zhao J M, Liang X F, Ying Teo Yik
机构信息
Chinese Preventive Medicine Association, Beijing 100021, China.
Chinese Preventive Medicine Association, Beijing 100021, China Kangtai Biological Vaccine Industry Research Institute, Jinan University, Guangzhou 510632, China.
出版信息
Zhonghua Liu Xing Bing Xue Za Zhi. 2022 Mar 10;43(3):310-314. doi: 10.3760/cma.j.cn112338-20211125-00919.
As of December 31, 2021, Singapore reported that 4 758 601 had completed at least one dose of COVID-19 vaccination, 4 714 655 had completed two doses of COVID-19 vaccination, and 2 207 341 had received one booster shot of COVID-19 vaccine. This article analyses the current performance of COVID-19 vaccination in Singapore, interprets the content of Singapore's National Vaccination Programme, and systematically introduces specific measures of COVID-19 vaccination in Singapore, such as door-to-door vaccination, vaccination differentiated management, and self-payment of medical expenses for those who refuse to be vaccinated, to provide reference for the COVID-19 vaccination in China.
截至2021年12月31日，新加坡报告称，4758601人已完成至少一剂新冠疫苗接种，4714655人已完成两剂新冠疫苗接种，2207341人已接种一剂新冠疫苗加强针。本文分析了新加坡新冠疫苗接种的现状，解读了新加坡国家疫苗接种计划的内容，并系统介绍了新加坡新冠疫苗接种的具体措施，如上门接种、接种差异化管理以及拒绝接种者自付医疗费用等，为中国的新冠疫苗接种提供参考。
Zotero 插件